Stock Updates

Is this Large Market Cap Stock target price reasonable for Nektar Therapeutics (NASDAQ:NKTR)?

The company in question is, Nektar Therapeutics (NASDAQ:NKTR) currently with a stock price of 15.99 (-0.56% today). The market cap for Nektar Therapeutics is 2223.54, and is in the sector Healthcare, and Biotechnology industry. The target price for Nektar Therapeutics is 20.83. Currently Nektar Therapeutics is trading with a P/E of *TBA, and a forward P/E of *TBA. Average volume for Nektar Therapeutics is 1173.32 and so far today it is 380818.

Performance in the last year for Nektar Therapeutics has been 61.12%. For EPS growth, Nektar Therapeutics has seen a growth of -44.20%, and is looking to grow in the next year to 18.90%. More long term stats show that EPS growth has been -8.70% over the last five years and could be -7.30% for the next five years. Nektar Therapeutics has seen sales growth quarter over quarter at 44.50%, with EPS growth quarter over quarter at 10.90%. The 20-day simple moving average is -10.45%, with the 200-day simple moving average coming to 5.93%.

Since the IPO date for Nektar Therapeutics on the 05/03/1994, Nektar Therapeutics has seen performance year to date to be -4.57%. With Nektar Therapeutics trading at 15.99, the dividend yield is *TBA, and the EPS is -0.97.

So could Nektar Therapeutics, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 11.64 and the P/B is at *TBA. The P/cash is 8.09, with P/free cash flow at *TBA.

Nektar Therapeutics ability to deal with debt shows that the current ratio is 4, and the quick ratio is 3.9. This is with long term debt/equity at *TBA, and total debt/equity at *TBA.

In terms of margins, Nektar Therapeutics has a gross margin of 83.40%, an operating margin of -47.50% and a profit margin of -68.30%.Payout ratio for Nektar Therapeutics is *TBA. Return on assets come to -27.40% with return on investment coming to -17.30%.

Insider ownership for Nektar Therapeutics, is at 0.80% and institutional ownership comes to 99.60%. Outstanding shares are at 138.28. While shares float is 135.86. The float short is currently 7.13%, and short ratio is 8.26.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment